These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 7886604)

  • 41. [Incidence of HBsAg among different population groups in Moldavia in 1991 compared with 1973].
    Iacob E; Avram G; Bivol A; Osiac E; Roman D; Despa D; Ivan A; Zavate O
    Rom J Virol; 1993; 44(1-2):55-60. PubMed ID: 9702249
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Prevalence of hepatitis B infection in the southeastern region of Turkey: comparison of risk factors for HBV infection in rural and urban areas.
    Mehmet D; Meliksah E; Serif Y; Gunay S; Tuncer O; Zeynep S
    Jpn J Infect Dis; 2005 Feb; 58(1):15-9. PubMed ID: 15728984
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Prevalence of VHB and VHC serological markers among blood donors in the capital state of Veracruz, Mexico].
    Valerio-Ureña J; Vásquez-Fernández F; Pérez-Sosa JA; Cortazar-Benitez LF; Chávez-Tapia NC; Ruvalcaba-Rojas OA; Torres-Medina V; Ocejo-Rodríguez A
    Gac Med Mex; 2009; 145(3):183-7. PubMed ID: 19685823
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Hepatitis B infection in households of HBsAg positive New Zealand children.
    Martin AR; Moyes CD; Lucas CR; Milne A
    N Z Med J; 1996 Dec; 109(1035):463-5. PubMed ID: 9006626
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Prevalence of HBsAg among the non cauterized groups of blood donors.
    Khalil IA; Elsheikh FS; Phrykian J; Phrykian S; Mitchell R
    East Afr Med J; 1996 Nov; 73(11):717-9. PubMed ID: 8997860
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Prevalence and genotypes of hepatitis C virus infection among drug addicts and blood donors in Thailand.
    Verachai V; Phutiprawan T; Theamboonlers A; Chinchai T; Tanprasert S; Haagmans BL; Osterhaus AD; Poovorawan Y
    Southeast Asian J Trop Med Public Health; 2002 Dec; 33(4):849-51. PubMed ID: 12757237
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Torquetenovirus infection among northeastern Thai blood donors.
    Urwijitaroon Y; Barusrux S; Chunlertlith K; Mairiang P; Yoshimura H
    Southeast Asian J Trop Med Public Health; 2007 Jul; 38(4):686-9. PubMed ID: 17883007
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Italian blood donors with anti-HBc and occult hepatitis B virus infection.
    Manzini P; Girotto M; Borsotti R; Giachino O; Guaschino R; Lanteri M; Testa D; Ghiazza P; Vacchini M; Danielle F; Pizzi A; Valpreda C; Castagno F; Curti F; Magistroni P; Abate ML; Smedile A; Rizzetto M
    Haematologica; 2007 Dec; 92(12):1664-70. PubMed ID: 18055990
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Donor screening for hepatitis B virus infection in a cell and tissue bank.
    Solves P; Mirabet V; Alvarez M; Vila E; Quiles F; Villalba JV; Montoro JA; Soler MA; Roig RJ
    Transpl Infect Dis; 2008 Dec; 10(6):391-5. PubMed ID: 18665905
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Prevalence of hepatitis B among Afghan refugees living in Balochistan, Pakistan.
    Quddus A; Luby SP; Jamal Z; Jafar T
    Int J Infect Dis; 2006 May; 10(3):242-7. PubMed ID: 16448838
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Post-transfusion hepatitis. Sudden drop of its incidence associated with hyperbilirubinemic donors disqualification.
    Pintera J; Krácmar C; Pinterová A
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1986; 113(3):415-25. PubMed ID: 2428716
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Study of hepatitis B surface antigen by 2 different serological methods].
    Bilgehan H; Bilgiç A
    Mikrobiyol Bul; 1977 Jul; 11(3):365-70. PubMed ID: 927228
    [TBL] [Abstract][Full Text] [Related]  

  • 53. AABB-CAP survey data on hepatitis--incidence, surveillance, and prevention.
    Polesky HF; Hanson M
    Am J Clin Pathol; 1980 Oct; 74(4 Suppl):565-8. PubMed ID: 7435449
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Epidemiological significance, clinico-morphological evaluation and behavior of pathogenetic factors, in asymptomatic chronic carriers of the HBsAg in the La Plata area. Study in voluntary blood donors].
    Jmelnitzky A; Basualdo JA; Landoni N; Ponce de León H; Morales V; Chopita N; Doria I; Fink N; Barbetti A; Castelletto R; Veron M; de Torre R
    Acta Gastroenterol Latinoam; 1982; 12(2):117-34. PubMed ID: 7158240
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [HBsAg in members of the Yugoslav army -- volunteer blood donors].
    Vajzović A
    Bilt Hematol Transfuz; 1978; 6(3):69-74. PubMed ID: 757671
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Hepatitis B antigenemia among blood donors: the changing scene.
    Moore BP; Perrault RA
    Can Med Assoc J; 1975 Jan; 112(1):53-4. PubMed ID: 1109725
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Hepatitis-B surface antigen and VDRL in healthy blood donors of Brunei Darussalam.
    Sebastian VJ; Bhattacharya S; Ray S; Ahmad MZ
    Singapore Med J; 1989 Dec; 30(6):568-70. PubMed ID: 2635403
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Seroprevalence of hepatitis B surface antigen (HBsAg) among first-time and sporadic blood donors in Greece: 1991-1996.
    Kyriakis KP; Foudoulaki LE; Papoulia EI; Sofroniadou KE
    Transfus Med; 2000 Sep; 10(3):175-80. PubMed ID: 10972911
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Prevalence of HBsAg and HBsAg sub-types in the Canadian blood-donor population.
    Buchner BK; Duravetz JS; Moore BP
    Rev Fr Transfus Immunohematol; 1979 Dec; 22(5):521-7. PubMed ID: 547350
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Prevention of hepatitis B in the surgical clinic].
    Shalimov SA; Frolov AF; Radzikhovskiĭ AP; Orgel' MIa; Martsinkovskiĭ LT; Pokrasen NM; Shevchenko LF; Anan'ev VA; Tat'ianko NV
    Vestn Khir Im I I Grek; 1987 Jun; 138(6):133-6. PubMed ID: 3672774
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.